Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma

Nat Chem Biol. 2020 Apr;16(4):479. doi: 10.1038/s41589-020-0508-y.

Authors

Nathan T Ross^#^{1

2}, Felix Lohmann^#³, Seth Carbonneau¹, Aleem Fazal¹, Wilhelm A Weihofen¹, Scott Gleim¹, Michael Salcius¹, Frederic Sigoillot¹, Martin Henault¹, Sarah H Carl⁴, Juan B Rodríguez-Molina⁵, Howard R Miller¹, Scott M Brittain¹, Jason Murphy¹, Mark Zambrowski¹, Geoffrey Boynton¹, Yuan Wang¹, Aye Chen¹, Gregory J Molind¹, Johannes H Wilbertz^{4

6}, Caroline G Artus-Revel⁴, Min Jia^{4

6}, Favour A Akinjiyan¹, Jonathan Turner³, Judith Knehr³, Walter Carbone³, Sven Schuierer³, John S Reece-Hoyes¹, Kevin Xie¹, Chitra Saran¹, Eric T Williams¹, Guglielmo Roma³, Matt Spencer¹, Jeremy Jenkins¹, Elizabeth L George¹, Jason R Thomas¹, Gregory Michaud¹, Markus Schirle¹, John Tallarico¹, Lori A Passmore⁵, Jeffrey A Chao⁴, Rohan E J Beckwith^#⁷

Affiliations

¹ Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
² Vertex Pharmaceuticals, Boston, MA, USA.
³ Novartis Institutes for BioMedical Research, Basel, Switzerland.
⁴ Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
⁵ Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
⁶ University of Basel, Basel, Switzerland.
⁷ Novartis Institutes for BioMedical Research, Cambridge, MA, USA. rohan.beckwith@novartis.com.

^# Contributed equally.

PMID: 32139909
DOI: 10.1038/s41589-020-0508-y

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Grants and funding

MC_U105192715/MRC_/Medical Research Council/United Kingdom